Dachaigh › Dermatitis Atopach (Eczema) › California › Los Angeles
Sgrùdaidhean clionaigeach Dermatitis Atopach (Eczema) ann an Los Angeles, CA
Tha aon sgrùdadh airson Dermatitis Atopach (Eczema) a’ lorg phàirtichean aig làrach ann no faisg air Los Angeles. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A’ fastadhSgrùdadh amharc
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
A’ fastadhÌre 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
A’ fastadhÌre 2
- Metropolis Dermatology - DTLA, Los Angeles
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
A’ fastadhÌre 2
- Investigational Site, Los Angeles
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
A’ fastadhÌre 2
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
A’ fastadhÌre 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A’ fastadhÌre 2
- Inmagene Site 23, Los Angeles
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
A’ fastadhÌre 2
- Enveda Investigative Site, Los Angeles
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
A’ fastadhÌre 2
- California Allergy and Asthma Medical Group, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
A’ fastadhÌre 2
- California Allergy and Asthma Medical Group, Los Angeles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
A’ fastadhSgrùdadh amharc
- Galderma Investigational Site 7099, Los Angeles
Sgrùdaidhean Dermatitis Atopach (Eczema) ann am bailtean eile
- New York City, NY13 sgrùdaidhean
- Washington, DC11 sgrùdadh
- San Antonio, TX10 sgrùdaidhean
- San Diego, CA10 sgrùdaidhean
- Birmingham, AL9 sgrùdaidhean
- Miami, FL9 sgrùdaidhean
- Dallas, TX8 sgrùdaidhean
- Huntington Beach, CA8 sgrùdaidhean
- Sacramento, CA8 sgrùdaidhean
- Troy, MI8 sgrùdaidhean
- Indianapolis, IN7 sgrùdaidhean
- Pittsburgh, PA7 sgrùdaidhean
Sgrùdaidhean eile ann an Los Angeles
- Aillse Sgamhain Neo-chealla-beag87 sgrùdaidhean
- Aillse (gach seòrsa)74 sgrùdaidhean
- Aillse a' bhroilleach73 sgrùdaidhean
- Aillse Prostata61 sgrùdaidhean
- Aillse colorectal59 sgrùdaidhean
- Ailse metastatach57 sgrùdaidhean
- Cancer Ovarian50 sgrùdaidhean
- Ailseachadh nan Sgamhan45 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil42 sgrùdaidhean
- Cancer Pancreatic35 sgrùdaidhean
- Ailse Endometrial34 sgrùdaidhean
- Melanoma34 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.